We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
656 hedge funds and large institutions have $12.4B invested in State Street SPDR S&P Biotech ETF in 2025 Q3 according to their latest regulatory filings, with 100 funds opening new positions, 151 increasing their positions, 243 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 63
20% more funds holding in top 10
Funds holding in top 10: 15 → 18 (+3)
16% more capital invested
Capital invested by funds: $10.7B → $12.4B (+$1.69B)
14.41% more ownership
Funds ownership: 200.2% → 214.61% (+14%)
5% more funds holding
Funds holding: 625 → 656 (+31)
24% less call options, than puts
Call options by funds: $2.38B | Put options by funds: $3.15B
38% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 243
Holders
656
Holders Change
+31
Holders Change %
+4.96%
% of All Funds
8.61%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.24%
New
100
Increased
151
Reduced
243
Closed
63
Calls
$2.38B
Puts
$3.15B
Net Calls
-$772M
Net Calls Change
+$5.45M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$418M |
| 2 |
JP Morgan Chase
New York
|
+$261M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$248M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$152M |
| 5 |
Barclays
London,
United Kingdom
|
+$134M |
Top Sellers
| 1 |
Citigroup
New York
|
-$168M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$154M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$148M |
| 4 |
Jane Street
New York
|
-$114M |
| 5 |
BC
Broadwater Capital
Boston,
Massachusetts
|
-$90.8M |
